- Global
- United States
- Australia
- United Kingdom
- Canada
- India
- China
- Argentina
- Austria
- Bahrain
- Bangladesh
- Belgium
- Bermuda
- Botswana
- Brazil
- Bulgaria
- Chile
- Colombia
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Ireland
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lithuania
- Luxembourg
- Malawi
- Malaysia
- Malta
- Mauritius
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Oman
- Pakistan
- Palestinian Authority
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Trinidad & Tobago
- Tunisia
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- Venezuela
- Vietnam
- Zambia
- Zimbabwe
🌎 Switch to Global Market
Pharmaceuticals & Biotech South Korean Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech South Korean Investing Ideas
There are no community narratives available.
Recently Updated Narratives
DS
Nike will leverage its dominant market position and brand recognition to drive future growth
Fair Value: US$43.01 53.3% overvalued intrinsic discount
15 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
YI
Alphabet (GOOGL): When Scale Meets Intelligence at the Infrastructure Level
Fair Value: US$192.54 70.7% overvalued intrinsic discount
23 followersusers have followed this narrative
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
YI
RELX: The Quiet Compounder Powering Law, Science, and Risk Intelligence
Fair Value: US$41.22 4.7% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
AG
A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Fair Value: CA$31.8 98.3% undervalued intrinsic discount
7k viewsusers have viewed this narrative
70 followersusers have followed this narrative
13 commentsusers have commented on this narrative
23 likesusers have liked this narrative
AL
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
Fair Value: US$16.25 422.2% overvalued intrinsic discount
8.3k viewsusers have viewed this narrative
73 followersusers have followed this narrative
1 commentusers have commented on this narrative
18 likesusers have liked this narrative
AN
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
Fair Value: US$253.02 26.9% undervalued intrinsic discount
10k viewsusers have viewed this narrative
1029 followersusers have followed this narrative
6 commentsusers have commented on this narrative
29 likesusers have liked this narrative
